Ashly E. Jordan, PhD, MPH
NYS Office of Addiction Services and Supports (OASAS) - Director of Research and Program Evaluation
Email: Ashly.Jordan@oasas.ny.gov
Education
PhD, Epidemiology, Graduate School of Public Health and Health Policy, City University of New York MPH, Biostatistics and Epidemiology, School of Public Health, City University of New York
Research Interests
Societal (structural, social, and political) determinants of population health and inequities, infectious disease epidemiology, people who use drugs, hepatitis C virus, HIV, multi-level data analysis BIO
Ashly Jordan is the Director of Research and Program Evaluation for the New York State Office of Addiction Services and Supports. She is an interdisciplinary epidemiologist with more than 15 years of applied research experience and public health practice focused on understanding how systems and interventions can improve health and social outcomes for people who use substances and who experience addiction. She has served as a consultant to the United Nations Office on Drugs and Crime. Dr. Jordan’s research has examined blood-borne and skin and soft tissue infections, tuberculosis, drug overdose, substance use epidemiology, and the impact of criminal legal involvement on substance use epidemiology and treatment trajectories. She has published extensively, including on prevention and care continua, Big Events theory, and novel metrics, and has served on study sections. Drawing on theory-based multi-level understanding of illness and health, and principles of health equity and social justice, Dr. Jordan’s research and public health practice has focused on the interplay between individual, social and structural factors on people who use substances. Projects
Principal Investigator, Leveraging Regulatory Flexibility for Methadone Take-home Dosing to Improve Retention in Treatment for Opioid Use Disorder: A Stepped-wedge Randomized Trial to Facilitate Clinic Level Changes. Active
Principal Investigator, NY MOVES: Evaluating the Impact of New York’s Methadone Outreach VEhicleS. Active
Publications
Recent
Bradley H, Nguyen TM, Li L, King R, Kamanu V, Sharifi Far S, Mack S, Luisi N, Li Y, Meng Y, Liu G, Zhang J, Jordan AE, Le L, Brodie PL, Jensen S, Clear A, Udo T, Inacio V, Rosenberg ES (2026).
A comparative analysis of methodological practices used in capture-recapture population size estimation: Opioid use disorder prevalence in New York State, 2020
American Journal of Epidemiology [Epub 2026 Jul 10]. doi: 10.1093/aje/kwag161.
A comparative analysis of methodological practices used in capture-recapture population size estimation: Opioid use disorder prevalence in New York State, 2020
American Journal of Epidemiology [Epub 2026 Jul 10]. doi: 10.1093/aje/kwag161.
Krawczyk N, Miller M, Frank D, Harris SJ, O'Rourke A, Song M, Ruelas-Vargas K, Gibbons JB, Jordan A, Saloner B (2026).
Mobile but still tied down: Challenges to scaling mobile methadone through a regulatory thicket
International Journal of Drug Policy, 155, 105394. doi: 10.1016/j.drugpo.2026.105394. PMCID: PMC13329969.
Mobile but still tied down: Challenges to scaling mobile methadone through a regulatory thicket
International Journal of Drug Policy, 155, 105394. doi: 10.1016/j.drugpo.2026.105394. PMCID: PMC13329969.
Frank D, Harris SJ, Song M, Miller M, Ruelas-Vargas K, O'Rourke A, Jordan AE, Saloner B, Krawczyk N (2026).
“It’s so much easier for them to just come to us”: A qualitative study examining the implementation of mobile methadone treatment serving a residential SUD treatment program
Addiction Science and Clinical Practice [Epub 2026 Jul 1]. doi: 10.1186/s13722-026-00692-0.
“It’s so much easier for them to just come to us”: A qualitative study examining the implementation of mobile methadone treatment serving a residential SUD treatment program
Addiction Science and Clinical Practice [Epub 2026 Jul 1]. doi: 10.1186/s13722-026-00692-0.
Miller M, Song M, Bessler A, Ruelas-Vargas K, Frank D, Harris SJ, Gibbons JB, Jordan AE, Krawczyk N, Saloner B (2026).
“How are we going to be able to pull that off?”: Staff perspectives on the early implementation of mobile medication units in New York State
Addiction Science and Clinical Practice, 21 (1), 51. doi: 10.1186/s13722-026-00694-y. PMCID: PMC13308191.
“How are we going to be able to pull that off?”: Staff perspectives on the early implementation of mobile medication units in New York State
Addiction Science and Clinical Practice, 21 (1), 51. doi: 10.1186/s13722-026-00694-y. PMCID: PMC13308191.
Bachhuber MA, Jordan AE, Piper BJ (2026).
Prescription stimulant consumption in the United States compared with 35 other countries
Health Affairs Scholar, 4 (6), qxag133. doi: 10.1093/haschl/qxag133.
Prescription stimulant consumption in the United States compared with 35 other countries
Health Affairs Scholar, 4 (6), qxag133. doi: 10.1093/haschl/qxag133.
Notable
Incidence and prevalence of hepatitis C virus infection among persons who inject drugs in New York City: 2006-2013
Drug and Alcohol Dependence, 152, 194-200. doi: 10.1016/j.drugalcdep.2015.03.039. PMCID: PMC4458155.
Hagan H, Jordan AE, Neurer J, Cleland CM (2015).
Incidence of sexually transmitted hepatitis C virus infection in HIV-positive men who have sex with men
AIDS, 29 (17), 2335-2345. doi: 10.1097/QAD.0000000000000834. PMCID: PMC4640945.
Perlman DC, Jordan AE, Uuskula A, Huong DT, Masson CL, Schackman BR, Des Jarlais DC (2015).
An international perspective on using opioid substitution treatment to improve hepatitis C prevention and care for people who inject drugs: Structural barriers and public health potential
International Journal of Drug Policy, 26 (11), 1056-1063. doi: 10.1016/j.drugpo.2015.04.015. PMCID: PMC4581906.
Ashly Jordan's MyBibliography Profile